vs
Side-by-side financial comparison of FVCBankcorp, Inc. (FVCB) and Laird Superfood, Inc. (LSF). Click either name above to swap in a different company.
FVCBankcorp, Inc. is the larger business by last-quarter revenue ($16.9M vs $13.3M, roughly 1.3× Laird Superfood, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 15.0%). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs 16.1%).
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
FVCB vs LSF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $16.9M | $13.3M |
| Net Profit | — | $-1.8M |
| Gross Margin | — | 34.1% |
| Operating Margin | 43.7% | -13.5% |
| Net Margin | — | -13.2% |
| Revenue YoY | 4377.5% | 15.0% |
| Net Profit YoY | — | -341.4% |
| EPS (diluted) | $0.31 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $16.9M | $13.3M | ||
| Q3 25 | $416.0K | $12.9M | ||
| Q2 25 | $15.8M | $12.0M | ||
| Q1 25 | $382.0K | $11.7M | ||
| Q4 24 | $378.0K | $11.6M | ||
| Q3 24 | $412.0K | $11.8M | ||
| Q2 24 | $415.0K | $10.0M | ||
| Q1 24 | $359.0K | $9.9M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $5.6M | $-975.1K | ||
| Q2 25 | $5.7M | $-362.2K | ||
| Q1 25 | $5.2M | $-156.2K | ||
| Q4 24 | — | $-398.4K | ||
| Q3 24 | $4.7M | $-166.1K | ||
| Q2 24 | $4.2M | $-239.1K | ||
| Q1 24 | $1.3M | $-1.0M |
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 43.0% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 40.0% |
| Q4 25 | 43.7% | -13.5% | ||
| Q3 25 | — | -7.7% | ||
| Q2 25 | 45.9% | -3.3% | ||
| Q1 25 | — | -1.9% | ||
| Q4 24 | — | -4.1% | ||
| Q3 24 | — | -2.3% | ||
| Q2 24 | — | -3.4% | ||
| Q1 24 | — | -11.0% |
| Q4 25 | — | -13.2% | ||
| Q3 25 | 1341.1% | -7.6% | ||
| Q2 25 | 36.0% | -3.0% | ||
| Q1 25 | 1352.1% | -1.3% | ||
| Q4 24 | — | -3.4% | ||
| Q3 24 | 1133.3% | -1.4% | ||
| Q2 24 | 1001.2% | -2.4% | ||
| Q1 24 | 373.3% | -10.3% |
| Q4 25 | $0.31 | — | ||
| Q3 25 | $0.31 | — | ||
| Q2 25 | $0.31 | — | ||
| Q1 25 | $0.28 | — | ||
| Q4 24 | $0.27 | — | ||
| Q3 24 | $0.25 | — | ||
| Q2 24 | $0.23 | — | ||
| Q1 24 | $0.07 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $253.6M | $11.5M |
| Total Assets | $2.3B | $19.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.1M | ||
| Q3 25 | — | $5.1M | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | $7.0M | ||
| Q4 24 | — | $8.3M | ||
| Q3 24 | — | $7.9M | ||
| Q2 24 | — | $7.6M | ||
| Q1 24 | — | $7.1M |
| Q4 25 | $253.6M | $11.5M | ||
| Q3 25 | $249.8M | $12.8M | ||
| Q2 25 | $243.2M | $13.4M | ||
| Q1 25 | $242.3M | $13.3M | ||
| Q4 24 | $235.4M | $13.2M | ||
| Q3 24 | $230.8M | $13.1M | ||
| Q2 24 | $226.5M | $12.6M | ||
| Q1 24 | $220.7M | $12.7M |
| Q4 25 | $2.3B | $19.2M | ||
| Q3 25 | $2.3B | $18.9M | ||
| Q2 25 | $2.2B | $20.4M | ||
| Q1 25 | $2.2B | $21.5M | ||
| Q4 24 | $2.2B | $19.3M | ||
| Q3 24 | $2.3B | $18.8M | ||
| Q2 24 | $2.3B | $18.0M | ||
| Q1 24 | $2.2B | $17.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.9M | $68.4K |
| Free Cash FlowOCF − Capex | $23.8M | — |
| FCF MarginFCF / Revenue | 140.7% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.9M | $68.4K | ||
| Q3 25 | $7.6M | $1.2M | ||
| Q2 25 | $3.3M | $-2.8M | ||
| Q1 25 | $5.4M | $-1.3M | ||
| Q4 24 | $18.2M | $339.2K | ||
| Q3 24 | $4.7M | $305.8K | ||
| Q2 24 | $1.6M | $642.7K | ||
| Q1 24 | $7.2M | $-422.3K |
| Q4 25 | $23.8M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $18.1M | — | ||
| Q3 24 | $4.6M | — | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $7.1M | — |
| Q4 25 | 140.7% | — | ||
| Q3 25 | 1818.0% | — | ||
| Q2 25 | 20.8% | — | ||
| Q1 25 | 1413.6% | — | ||
| Q4 24 | 4786.0% | — | ||
| Q3 24 | 1121.8% | — | ||
| Q2 24 | 361.2% | — | ||
| Q1 24 | 1988.3% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 14.1% | — | ||
| Q2 24 | 12.8% | — | ||
| Q1 24 | 3.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 5.34× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FVCB
Segment breakdown not available.
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
